Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

RESPALERT

K-Number: K992618 · 1999-10-29

Decision Date1999-10-29
Product CodeBZH
Advisory CommitteeAN
DecisionSubstantially Equivalent

Device Summary

RESPALERT is the device name listed in this FDA 510(k) record. The listed applicant is Harwill Medical (Pty) , Ltd.. It received FDA 510(k) clearance on 1999-10-29 under 510(k) number K992618. The device is classified under product code BZH. It was reviewed by the AN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the RESPALERT?

RESPALERT is a medical device that received FDA 510(k) clearance on 1999-10-29. The listed applicant is Harwill Medical (Pty) , Ltd.. The 510(k) number is K992618.

When did RESPALERT receive FDA 510(k) clearance?

RESPALERT received FDA 510(k) clearance on 1999-10-29, under 510(k) number K992618.

Who is the listed applicant for RESPALERT?

The FDA 510(k) record lists Harwill Medical (Pty) , Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for RESPALERT?

The FDA product code for RESPALERT is BZH.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing Harwill Medical (Pty) , Ltd. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: BZH)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑